256446-66-9

Basic information

• Product Name: (R)-1,4-bis((benzyloxy)carbonyl)piperazine-2-carboxylic acid
• Synonyms: (R)-1,4-bis((benzyloxy)carbonyl)piperazine-2-carboxylic acid
• CAS NO: 256446-66-9
• Molecular Weight: 398.415
• Mol File: 256446-66-9.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (R)-1,4-bis((benzyloxy)carbonyl)piperazine-2-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-1,4-bis((benzyloxy)carbonyl)piperazine-2-carboxylic acid(256446-66-9)
• EPA Substance Registry System: (R)-1,4-bis((benzyloxy)carbonyl)piperazine-2-carboxylic acid(256446-66-9)

Safety Data

• Hazardous Substances Data: 256446-66-9(Hazardous Substances Data)

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 501-53-1 benzyl chloroformate 
• 31321-68-3 (R)-piperazine-2-carboxylic acid 

Downstream Products

• 1058723-73-1 C₂₂H₂₂N₄O₅ 
• 1058723-74-2 C₂₄H₂₈N₂O₆ 
• 943816-06-6 (R)-piperazine-2-ylmethyl tert-butyldiphenylsilylether 

Relevant articles and documents

C26-LINKED RAPAMYCIN ANALOGS AS MTOR INHIBITORS

The present disclosure relates to mTOR inhibitors. Specifically, the embodiments are directed to compounds and compositions inhibiting mTOR, methods of treating diseases mediated by mTOR, and methods of synthesizing these compounds.

OPTICALLY ACTIVE TRIETHYLENEDIAMINE DERIVATIVE AND METHOD FOR PRODUCING THE SAME

PROBLEM TO BE SOLVED: To provide an optically active triethylenediamine derivative useful as an asymmetric reagent and a method of producing the same. SOLUTION: An optically active (R or S)-(hydroxymethyl) triethylenediamine represented by formula (1b) (w

FARNESYL PROTEIN TRANSFERASE INHIBITORS

Disclosed are compounds of formula (1.0), wherein R represents a cyclic moiety to which is bound an imodazolylalkyl group; R represents a carbamate, urea, amide or sulfonamide group; and the remaining substituents are as defined herein. Also disclosed is a method of treating cancer and a method of inhibiting farnesyl protein transferase using the disclosed compounds.